Medicare Cbd Coverage Policy, Medicare Cannabidiol Regulation, Cbd Insurance Reimbursement, Fda Drug Approval Bypass, Cbd Clinical Evidence Standards

Medicare’s CBD Gamble: Is Washington About to Bypass FDA Drug Approval?

By Benjamin Caplan, MD

Comments Off on Medicare’s CBD Gamble: Is Washington About to Bypass FDA Drug Approval?

March 10, 2026

3 Min Read

Medicare CBD coverage policy may bypass FDA drug approval, raising concerns about product quality and safety. Clinicians face challenges due to uncertain dosing and evidence standards. This regulatory shift could impact patient care and clinical…